
LMAT
USDLeMaitre Vascular Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$83.000
Máximo
$89.010
Mínimo
$81.570
Volumen
0.06M
Fundamentos de la Empresa
Capitalización de Mercado
2.0B
Industria
Medical Instruments & Supplies
País
United States
Estadísticas de Negociación
Volumen Promedio
0.17M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Informe de Análisis de IA
Última actualización: 30 oct 2025LMAT Analysis: LeMaitre Vascular Faces Key Inflection Point Ahead of Earnings
Price Action: Volatility and Support Testing
LeMaitre Vascular (LMAT) has experienced a rollercoaster ride over the past three months. The stock surged from $81 to $93.04 in early August (+15%) but later dropped to $84.66 in late September (-9%), only to stabilize near $88.55 as of October 30. Key patterns to note:
- Support Zone Alert: The stock hovers near $89.16, a critical support level. Recent lows on October 29 ($88.33) and October 30 ($87.82) suggest sellers are testing this level.
- Volume Contrasts: Surge days (August 6: +18%, volume 428,600) contrast sharply with the 509,700 volume crash on August 26 (-5%), indicating emotional retail trader involvement.
- Technical Tug-of-War: Mixed signals - the MACD "death cross" warns of bearish momentum, while the OBV spike on October 30 shows sudden buying pressure.
Sentiment: Analysts Push Against Market Skepticism
- Positive Catalyst: Barrington Research reiterated its $95 price target on October 15, implying 7.2% upside from current levels. 8 analysts collectively project a $104.62 average target (+17.9% potential).
- Earnings Countdown: The company’s Q3 results (November 6) create a natural inflection point. Historical volatility around reporting dates could amplify moves post-announcement.
- Market Disconnect: Despite the analyst optimism, the stock underperforms its 52-week high ($109.58) by 19% and trades below its P/E ratio of 40.81, which the model flags as "neutral" (not overvalued nor undervalued).
Predictive Outlook: AI Detects Short-Term Momentum
AI models project a cautious upside over 3 days:
- Day 1: +0.2% (flat move, low confidence)
- Day 2: +2.6% (strongest signal)
- Day 3: +2.3% (sustained momentum) Combined with the $91.57 AI target, this suggests potential rebound energy if support at $89.16 holds. However, the technical DMI (-DI 12.5 vs. +DI 8.8) warns of unresolved bearish pressure.
Strategic Guidance: Play the Range, Watch Debt Shadows
Entry Opportunities: If volume surges above 150,000, consider nibbling at shares near the support cluster ($89.09-$90.30). The technical setup favors a bounce, but the high debt-to-equity ratio (51.
Noticias Relacionadas
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular with a Outperform and maintains $95 price target.
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market
Predicción de IABeta
Recomendación de IA
Actualizado el: 10 nov 2025, 10:37
63.1% Confianza
Riesgo y Negociación
Punto de Entrada
$86.47
Toma de Ganancias
$88.43
Stop Loss
$78.02
Factores Clave
Acciones Relacionadas
XOMAP
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
CABO
Cable One Inc.
KTTA
Pasithea Therapeutics Corp.
ROIC
Retail Opportunity Investments Corp. (MD)
TG
Tredegar Corporation
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.